BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17456316)

  • 1. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
    Yang XH; Liu BR; Jiang HC
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study.
    Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK
    Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
    Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.
    Lee WC; Wu TJ; Chou HS; Yu MC; Hsu PY; Hsu HY; Wang CC
    Surgery; 2012 Feb; 151(2):213-22. PubMed ID: 21975289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on expressions of CD25 and CD127 in CD4+ peripheral T lymphocytes of patients with rheumatoid arthritis].
    Huang ZX; Zheng BR; Li TW; Lu YM; Gu JR; Han XY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2476-80. PubMed ID: 20137434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma.
    Takata Y; Nakamoto Y; Nakada A; Terashima T; Arihara F; Kitahara M; Kakinoki K; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Cancer Lett; 2011 Aug; 307(2):165-73. PubMed ID: 21530074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
    Nie ST; Li Q; Wang HY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor activity among CD4+,CD25++ T cells is discriminated by membrane-bound tumor necrosis factor alpha.
    Wang J; van Dongen H; Scherer HU; Huizinga TW; Toes RE
    Arthritis Rheum; 2008 Jun; 58(6):1609-18. PubMed ID: 18512781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA; Hillemann T; Wedemeyer H; Manns MP; Greten TF; Korangy F
    Cancer Res; 2005 Mar; 65(6):2457-64. PubMed ID: 15781662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decrease of FOXP3 mRNA in CD4+ T cells in latent autoimmune diabetes in adult].
    Yang ZF; Zhou ZG; Tang WL; Huang G; Peng J; Li X; He L
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2533-6. PubMed ID: 17198560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis.
    Wei CM; Lee JH; Wang LC; Yang YH; Chang LY; Chiang BL
    J Microbiol Immunol Infect; 2008 Feb; 41(1):78-87. PubMed ID: 18327431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
    Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.